VANGUARD GROUP INC 13D and 13G filings for Infinity Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 11:22 am Sale |
2022-12-30 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
VANGUARD GROUP INC | 5,313,679 5.950% |
-469,754 (-8.12%) |
Filing |
| 2022-02-10 08:17 am Purchase |
2021-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
VANGUARD GROUP INC | 5,783,433 6.500% |
3,888,514 (+205.21%) |
Filing |